Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C
Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C
The current gold standard for treatment of chronic hepatitis C (CHC) patients is with pegylated interferon plus ribavirin. Drug administration accuracy and ease of use will definitely determine treatment effectiveness. This is the idea behind the development and usage of the PegPen. The goal of this study is to determine the satisfaction grade with this novel device.
Enrollment of patients will occur in a sequential order of treatment initiation.
Inclusion Criteria:
Exclusion Criteria: